IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.
Recruitment status was: Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.
The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.
| Condition | Intervention |
|---|---|
| Stroke Transient Ischemic Attack | Behavioral: Smoking cessation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Prevention |
| Official Title: | Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack. A Randomised Controlled Trial |
- Smoking cessation rate
| Estimated Enrollment: | 300 |
| Study Start Date: | February 2005 |
| Estimated Study Completion Date: | February 2007 |
Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.
The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.
Patients with stroke or transient ischemic attack are admitted to the department of neurology at Odense University hospital. Patient who are smokers on admission and age < 76 years, inhabitants in Funen County and with symptoms developed before admission will be offered participation in the study unless they have severe stroke, stroke more than 3 weeks before admission, other severe disease or unable to participate.
Study participants will be randomised to either usual short advise on smoking cessation or an intensive smoking cessation program. All participants will be followed-up for 6 months with regard to smoking habits.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age < 76 years
- Inhabitant in Funen County
- Acute stroke or transient ischemic attack
- Symptoms with onset before admission
- Current smoker on admission
Exclusion Criteria:
- Severe stroke
- Current stroke onset more than 3 weeks before admission
- Other severe disease
- Unable to participate
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00228098
| Denmark | |
| Department of Neurology | Recruiting |
| Odense, Funen, Denmark, 5000 C | |
| Contact: Søren Bak, MD, PhD. bak@hunderupnet.dk | |
| Principal Investigator: | Søren Bak, MD, PhD | Department of Neurology, Odense University Hospital. 5000 Odense C. Denmark |
More Information
| ClinicalTrials.gov Identifier: | NCT00228098 History of Changes |
| Other Study ID Numbers: |
VF 20040136 |
| Study First Received: | September 26, 2005 |
| Last Updated: | September 27, 2005 |
Additional relevant MeSH terms:
|
Ischemia Ischemic Attack, Transient Brain Ischemia Stroke Cerebrovascular Disorders Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on August 18, 2017